A new missense mutation in FGF23 gene in a male with hyperostosis-hyperphosphatemia syndrome (HHS)

Gene

Volumn 542, Issue 2, 2014, Pages 269-271

  Abbasi, Farzaneh ^a   Ghafouri Fard, Soudeh ^b   Javaheri, Mona ^b   Dideban, Abdullah ^a   Ebrahimi, Ayoub ^a   Ebrahim Habibi, Azadeh ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; CHILD, PRESCHOOL; COMPUTER SIMULATION; FIBROBLAST GROWTH FACTORS; HOMOZYGOTE; HUMANS; HYPEROSTOSIS; HYPERPHOSPHATEMIA; MALE; MUTATION, MISSENSE; N-ACETYLGALACTOSAMINYLTRANSFERASES; PROTEIN CONFORMATION;

EID: 84898806088     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.03.052     Document Type: Letter

References (8)

1. Frishberg Y., Topaz O., Bergman R., et al. Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders. Journal of Molecular Medicine 2005, 83(1):33-38.
2. Garringer H.J., Mortazavi S.M., Esteghamat F., et al. Two novel GALNT3 mutations in familial tumoral calcinosis. American Journal of Medical Genetics Part A 2007, 143A(20):2390-2396.
3. Garringer H.J., Malekpour M., Esteghamat F., et al. Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis. American Journal of Physiology - Endocrinology and Metabolism 2008, 295(4):E929-E937.
4. Goetz R., Beenken A., Ibrahimi O.A., et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Molecular and Cellular Biology 2007, 27(9):3417-3428.
5. Ichikawa S., Lyles K.W., Econs M.J. A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive. Journal of Clinical Endocrinology and Metabolism 2005, 90(4):2420-2423.
6. Ichikawa S., Baujat G., Seyahi A., et al. Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations. American Journal of Medical Genetics Part A 2010, 152A(4):896-903.
7. Joseph L., Hing S.N., Presneau N., et al. Familial tumoral calcinosis and hyperostosis-hyperphosphataemia syndrome are different manifestations of the same disease: novel missense mutations in GALNT3. Skeletal Radiology 2010, 39(1):63-68.
8. Mikati M.A., Melhem R.E., Najjar S.S. The syndrome of hyperostosis and hyperphosphatemia. Journal of Pediatrics 1981, 99(6):900-904.